Open AccessResponse to Treatment in 4T1 Tumor Following Exposure to Paclitaxel and Doxorubicin Based on Antiangiogenic Effects
Author(s) -
Zahra Valizadeh,
Masoomeh Beheshti,
Fatemeh Ashrafi,
Soyar Sari,
Raheleh Kheirbakhsh,
Hadiseh Mohammadpour,
Samad Mohammadnejad,
Ahad Mohammadnejad,
Saeid Amanpour,
Marveh Rahmati
Publication year - 2022
Publication title -
basic and clinical cancer research
Language(s) - English
Resource type - Journals
eISSN - 2228-6527
pISSN - 2228-5466
DOI - 10.18502/bccr.v13i2.10031
Subject(s) - medicine , angiogenesis , paclitaxel , doxorubicin , h&e stain , chemotherapy , immunohistochemistry , breast cancer , triple negative breast cancer , cancer , cancer research , pathology , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom